118 related articles for article (PubMed ID: 20512258)
1. [Serum markers of oxidative stress and assisted reproduction procedures results in infertile patients with polycystic ovary syndrome and controls].
Rodrigues JK; Dib LA; Ferriani RA; Jordão Junior AA; Navarro PA
Rev Bras Ginecol Obstet; 2010 Mar; 32(3):118-25. PubMed ID: 20512258
[TBL] [Abstract][Full Text] [Related]
2. Increased oxidative stress is associated with insulin resistance and infertility in polycystic ovary syndrome.
Özer A; Bakacak M; Kıran H; Ercan Ö; Köstü B; Kanat-Pektaş M; Kılınç M; Aslan F
Ginekol Pol; 2016; 87(11):733-738. PubMed ID: 27958630
[TBL] [Abstract][Full Text] [Related]
3. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
4. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
[TBL] [Abstract][Full Text] [Related]
5. [Serum markers of oxidative stress in infertile women with endometriosis].
Andrade AZ; Rodrigues JK; Dib LA; Romão GS; Ferriani RA; Jordão Junior AA; Navarro PA
Rev Bras Ginecol Obstet; 2010 Jun; 32(6):279-85. PubMed ID: 20945013
[TBL] [Abstract][Full Text] [Related]
6. Increased concentration of 8-hydroxy-2'-deoxyguanosine in follicular fluid of infertile women with endometriosis.
Da Broi MG; de Albuquerque FO; de Andrade AZ; Cardoso RL; Jordão Junior AA; Navarro PA
Cell Tissue Res; 2016 Oct; 366(1):231-42. PubMed ID: 27250533
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and polycystic ovary syndrome: evaluation during ovarian stimulation for ICSI.
Melo AS; Kliemchen J; Junior AA; Ferriani RA; Navarro PA
Reproduction; 2016 Oct; ():. PubMed ID: 27799629
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality.
Liu Y; Yu Z; Zhao S; Cheng L; Man Y; Gao X; Zhao H
J Assist Reprod Genet; 2021 Feb; 38(2):471-477. PubMed ID: 33216309
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of counting follicles in diagnosis of polycystic ovary syndrome by the three-dimensional ultrasound imaging with sonography based automated volume calculation method].
He LR; Zhou LX; Pan RK; Zhang X
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):350-4. PubMed ID: 21733371
[TBL] [Abstract][Full Text] [Related]
10. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
[TBL] [Abstract][Full Text] [Related]
11. Role of vitamin E and D
Fatemi F; Mohammadzadeh A; Sadeghi MR; Akhondi MM; Mohammadmoradi S; Kamali K; Lackpour N; Jouhari S; Zafadoust S; Mokhtar S; Giahi L
Clin Nutr ESPEN; 2017 Apr; 18():23-30. PubMed ID: 29132734
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC
J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
[TBL] [Abstract][Full Text] [Related]
13. Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis.
Fallat ME; Siow Y; Marra M; Cook C; Carrillo A
Fertil Steril; 1997 May; 67(5):962-5. PubMed ID: 9130910
[TBL] [Abstract][Full Text] [Related]
14. Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes.
Cela V; Obino MER; Alberga Y; Pinelli S; Sergiampietri C; Casarosa E; Simi G; Papini F; Artini PG
Gynecol Endocrinol; 2018 Jun; 34(6):518-523. PubMed ID: 29271274
[TBL] [Abstract][Full Text] [Related]
15. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
Dewailly D; Lujan ME; Carmina E; Cedars MI; Laven J; Norman RJ; Escobar-Morreale HF
Hum Reprod Update; 2014; 20(3):334-52. PubMed ID: 24345633
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
17. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.
Lu XE; Huang HF; Li MG; Zhu YM; Qiang YL; Dong MY
J Zhejiang Univ Sci B; 2005 Sep; 6(9):897-902. PubMed ID: 16130192
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Oxidative Stress in Women with Polycystic Ovarian Syndrome as Represented by Serum Ischemia Modified Albumin and Its Correlation with Testosterone and Insulin Resistance.
Beyazit F; Yilmaz N; Balci O; Adam M; Yaman ST
Intern Med; 2016; 55(17):2359-64. PubMed ID: 27580534
[TBL] [Abstract][Full Text] [Related]
19. The association between dietary antioxidants, oxidative stress markers, abdominal obesity and poly-cystic ovary syndrome: A case control study.
Shahrokhi SA; Naeini AA
J Obstet Gynaecol; 2020 Jan; 40(1):77-82. PubMed ID: 31304805
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women.
Pearce K; Gleeson K; Tremellen K
Hum Reprod; 2015 Sep; 30(9):2171-7. PubMed ID: 26202912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]